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Purpose. Liver cirrhosis associated with high perioperative morbidity/mortality. This retrospective study determines whether liver
cirrhosis represents a risk factor for anastomotic leakage after colonic anastomosis or not.Methods. Based on a prospective database
with all consecutive colorectal resections performed at the authors’ institution from 07/2002 to 07/2012 (𝑛 = 2104) all colonic and
rectal anastomoses were identified (𝑛 = 1875). A temporary loop ileostomy was constructed in 257 cases (13.7%) either due to
Mannheimer Peritonitis-Index > 29 or rectal anastomosis below 6 cm from the anal verge. More than one-third of the patients
(𝑛 = 691) had postoperative contrast enema, either at the occasion of another study or prior to closure of ileostomy. The presence
of liver cirrhosis and the development of anastomotic leakagewere assessed by chart review.Results.The overall anastomotic leakage
rate was 2.7% (50/1875). In patients with cirrhosis/severe fibrosis, the anastomotic leakage rate was 12.5% (3/24), while it was only
2.5% (47/1851) in thosewithout (𝑝 = 0.024).The difference remained statistically significant after correction for confounding factors
by multivariate analysis. Conclusion. Patients with liver cirrhosis/severe fibrosis have an increased risk of leakage after colonic
anastomosis.
1. Introduction
How to deal with patients with known or unexpected liver
cirrhosis remains a major challenge in colorectal surgery
as liver cirrhosis bears a high risk of postoperative com-
plications [1–5]. Although the morbidity and mortality in
these patients have been studied [6–10], surprisingly little
is known regarding the relation between liver cirrhosis and
anastomotic leakage as the most feared complication after
colorectal surgery.
Although the healing of an intestinal anastomosis has
often been studied but remains poorly understood [11], there
are several disturbances that might influence the anasto-
motic healing in patients with liver cirrhosis: first, portal
hypertension with impaired regulation of splanchnic blood
flow [12], second, the protein metabolism disorder [13],
and, third, the immune dysfunction syndrome especially in
presence of ascites [14]. Indeed factors correlatedwith adverse
surgical outcome in patients with liver cirrhosis are higher
intraoperative blood loss reflecting portal hypertension,
hypalbuminemia reflecting proteinmetabolism disorder, and
the presence of ascites [15]. Furthermore the severity of liver
disease correlates with postoperativemorbidity andmortality
[16].
To our knowledge only animal models have shown a
relationship between liver cirrhosis and anastomotic leakage
so far [17]. This study determines, for the first time, whether
liver cirrhosis is a risk factor for anastomotic leakage after
colorectal surgery or not.
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Consecutive colorectal resections done from 07/2003 to 07/2012
at the authors’ institution (n = 2104)
Patients without anastomosis (n = 229)
Patients with colorectal resection and anastomosis (n = 1875)
Absence of cirrhosis or severe
fibrosis (n = 1851)
Presence of cirrhosis or
severe fibrosis (n = 24)
Figure 1: Flow diagram of the study methodology.
2. Methods
Based on an existing prospective colorectal database with
all consecutive colorectal operations resections, all colonic
and rectal anastomoses performed at the authors’ institution
from 07/2002 to 07/2012 were retrospectively identified (𝑛 =
1875). Regardless of the localization of the anastomosis an
end-end anastomosis was always performed. In the case of
rectal anastomosis double stapling technique using a circular
stapler with a diameter of 33mmwas used and coloanal anas-
tomosis was done with a single layered single-stitch suture
with polydioxanone USP 5-0, while in the case of colonic
anastomosis a hand-sewn anastomosis was done using a
continuous double-layered suture with polydioxanone USP
5-0.
The policy on when to construct a temporary loop ileo-
stomy (𝑛 = 257 cases, 13.7%) was as follows: Mannheimer
Peritonitis-Index [18] higher than 29 and/or low rectal anas-
tomosis up to 6 cm from anal verge.
The diagnosis of liver cirrhosis/severe fibrosis was based
on the finding of a typical nodular surface of the liver during
surgery and/or on liver biopsy. Histologically staging of fibro-
sis/cirrhosis was performed using the Ishak scoring system
which defines cirrhosis for stages 5 and 6 and advanced
fibrosis in stage 4 [19].
The development of anastomotic leakage and the risk
factors were retrospectively assessed based on chart review.
A planned contrast enema was done in more than one-
third of the patients (𝑛 = 691) either at the occasion of
another study (prospective) or prior to closure of temporary
loop ileostomy. In the remaining patients a CT scan with
contrast enema was only done in the case of the presence of
signs of anastomotic leakage, such as abdominal pain, fever,
and elevation of inflammation markers (e.g., CRP elevation
after postoperative day 3).
An anastomotic leak was defined as the extravasation of
water-soluble contrast in the contrast enema or CT scan,
a detected fluid collection (containing air bubbles and/or
surrounded by a wall with contrast enhancement), fecal
abdominal drainage, the intraoperative finding of anasto-
motic leakage, or the combination of two or more of these
factors. An overview of the study methodology is presented
in Figure 1.
Table 1: Patients’ characteristics.
Risk factor
Liver cirrho-
sis/severe
fibrosis (total
𝑛 = 24)
No liver cir-
rhosis/severe
fibrosis (total
𝑛 = 1851)
𝑝 value
Mean age (SD) 65.5 (11.6) 65.0 (14.4) 0.943
Male gender 17 (71%) 892 (48%) 0.039
Median ASA score
(range) 3 (2–4) 2 (1–5) 0.002
Cardiac comorbidities 19 (79%) 818 (44%) 0.008
Vascular comorbidities 3 (13%) 176 (10%) 0.737
Diabetes 6 (25%) 157 (8%) 0.022
Pulmonary
comorbidities 9 (38%) 224 (12%) 0.003
Tobacco abuse 7 (29%) 269 (15%) 0.094
Obesity 18 (75%) 948 (51%) 0.086
Dementia 3 (13%) 20 (1%) 0.004
Immunosuppressive
drugs 1 (4%) 83 (4%) 1.000
Nonsteroidal
anti-inflammatory
drugs
4 (17%) 248 (13%) 0.770
Presence of cancer 11 (46%) 537 (29%) 0.131
Presence of peritonitis 4 (17%) 173 (9%) 0.294
Large bowel
obstruction 1 (4%) 103 (6%) 1.000
SD: standard deviation; ASA: American Society of Anesthesiologists.
2.1. Statistics. Results are expressed as median and range or
mean and standard deviationwhenever appropriate. Categor-
ical data was analyzed with the two-sided Fisher’s exact test.
Continuous data was analyzed with the Wilcoxon rank sum
score. Multivariate analyses were done by logistic regression.
𝑝 values < 0.05 were considered statistically significant.
2.2. Ethics Statement. This retrospective study was approved
by the ethical committee of northwestern and central Switzer-
land (EKNZ Number BASEC 2016-01311).
3. Results
The overall anastomotic leakage rate was 2.7% (50/1875).
Among patients who developed an anastomotic leakage 𝑛 = 6
(12%) were asymptomatic and only detected by imaging, 𝑛 =
8 (16%) were managed conservatively, and 𝑛 = 36 (72%)
required revision laparotomy.
The patients’ characteristics are shown in Table 1 and
the results of the univariate analyses of the risk factors for
an anastomotic leak are shown in Table 2. The significantly
higher leak rate in the case of presence of liver cirrho-
sis/severe fibrosis is shown in Figure 2.
Table 3 shows the results of the multivariate analyses
where only male gender, lower albumin level, intake of
immunosuppressive drugs, and the presence of severe fibro-
sis/cirrhosis remained statistically significant predictors of
the development of an anastomotic leak after colonic surgery.
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Table 2: Results of the univariate analyses of the risk factors of
anastomotic leakage after colonic anastomosis.
Risk factor Anastomoticleak (𝑛 = 50)
No anastomotic
leak (𝑛 = 1805) 𝑝 value
Mean age (SD) 68.8 (14.9) 64.9 (14.4) 0.028
Male gender 𝑛 = 33 𝑛 = 876 0.021
Median ASA score
(Range) 2 (1–4) 2 (1–5) 0.156
Cardiac
comorbidities 𝑛 = 28 𝑛 = 810 0.322
Vascular
comorbidities 𝑛 = 5 𝑛 = 174 1.000
Diabetes 𝑛 = 10 𝑛 = 153 0.022
Pulmonary
comorbidities 𝑛 = 9 𝑛 = 224 0.396
Tobacco abuse 𝑛 = 7 𝑛 = 269 0.437
Obesity 𝑛 = 28 𝑛 = 938 1.000
Dementia 𝑛 = 2 𝑛 = 21 0.142
Immunosuppressive
drugs 𝑛 = 7 𝑛 = 77 0.010
Nonsteroidal
anti-inflammatory
drugs
𝑛 = 7 𝑛 = 245 1.000
Presence of cancer 𝑛 = 16 𝑛 = 532 1.000
Presence of
peritonitis 𝑛 = 5 𝑛 = 172 1.000
Large bowel
obstruction 𝑛 = 3 𝑛 = 101 1.000
Liver cirrhosis or
severe fibrosis 𝑛 = 3 𝑛 = 21 0.024
Mean (SD) white
blood cell count
(1/10𝐸9)
8.5 (3.8) 8.2 (4.0) 0.300
Mean (SD)
haemoglobin level 12.7 (2.4) 13.3 (2.0) 0.084
Mean (SD) sodium
level 138.9 (4.2) 140.0 (3.1) 0.471
Mean (SD)
potassium level 4.1 (0.5) 4.1 (1.1) 0.757
Mean (SD)
creatinine level 88.4 (48) 79.6 (43.6) 0.131
Mean (SD) albumin
level 37.6 (4.8) 40.2 (5.7) <0.001
SD: standard deviation; ASA: American Society of Anesthesiologists.
3.1. Subgroup Analyses. Patients with liver cirrhosis/severe
fibrosis with anastomotic leakage revealed Child-Pugh-
Turcotte scores A (𝑛 = 1) and B (𝑛 = 2), while those without
anastomotic leakage had the following Child-Pugh-Turcotte
scores A (𝑛 = 14), B (𝑛 = 4), and C (𝑛 = 1); 𝑛 = 2 missing
data. Patients with Child B or C score had no significantly
higher anastomotic leakage rate after colorectal surgery than
those with Child A score (𝑝 = 0.227).
From 𝑛 = 79 patients with colorectal surgery without
performed anastomosis 𝑛 = 72 patients had sphincter saving
procedures, while 𝑛 = 7 had nonsphincter saving procedures.
p = 0.024
47/1851
No cirrhosis or
severe fibrosis
Cirrhosis and/or
severe fibrosis
3/24
0
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Figure 2: Anastomotic leak rate in absence versus in presence of
liver cirrhosis and/or severe fibrosis.
Table 3: Results of the multivariate analyses of the detected risk
factors for anastomotic leakage after colonic anastomosis.
Risk factor Odds ratio 95% confidenceinterval 𝑝 value
Male gender 2.3 1.1–4.4 0.021
Age 1.0 1.0–1.1 0.422
Diabetes 1.4 0.6–3.5 0.439
Albumin level 1.0 0.9–1.0 0.042
Immunosuppressive
drugs 2.9 1.0–7.9 0.045
Liver cirrhosis or
severe fibrosis 4.1 1.1–15.5 0.036
ASA: American Society of Anesthesiologists.
The indications for surgery were 𝑛 = 26 perforated sigmoid
diverticulitis, 𝑛 = 14 anastomotic leakage, 𝑛 = 7 colon
ischemia, 𝑛 = 8 colonic perforation of other origin, 𝑛 = 11
colorectal cancer, 𝑛 = 8 noncolorectal cancer, 𝑛 = 3 chronic
inflammatory bowel disease, 𝑛 = 1 rectal prolapse, and 𝑛 = 1
perianal abscess. The rate of liver cirrhosis in these patients
was not significantly higher (2.5%, 2/79) than in the popula-
tion with anastomosis performed (1.3%, 24/1875, 𝑝 = 0.288).
From 71 patients with reversal of a colostomy only two
patients had liver cirrhosis/or high-grade fibrosis. These two
patients did not develop anastomotic leakage.
4. Discussion
Liver cirrhosis is a known major risk factor for postopera-
tive complications in general and colorectal surgery with a
reportedmorbidity of up to 50% andmortality up to 25%.The
severity of the disease correlateswith postoperativemorbidity
and mortality [16]. Surprisingly little is known about the
connection between liver cirrhosis and anastomotic leakage
after colorectal surgery [17]. Nevertheless surgeons dislike
or even avoid performing colonic or rectal anastomosis in
patients with liver cirrhosis.
4 Gastroenterology Research and Practice
The present study aimed to determine if liver cirrho-
sis/severe fibrosis represents a risk factor for leakage after
colorectal surgery or not. Indeed the results support the
assumption that cirrhosis/severe fibrosis is a significant risk
factor for the development of an anastomotic leak after
colorectal surgery.
The presented data complies with earlier reports show-
ing that cirrhotic patients are in an immunocompromised
state with a high risk for bacterial translocation and septic
conditions [14, 20]. As in other studies hypalbuminemia as a
marker of liver dysfunction was shown to be associated with
anastomotic leakage [21–23].
Which measures can be taken to lower the risk of
anastomotic leakage in colorectal surgery in patients with
liver cirrhosis?
First, pharmacotherapy of patients with liver cirrhosis
should be optimized prior to surgery, particularly regarding
portal hypertension [24]. For the latter, appropriate treatment
with nonselective beta-blockers should be implemented. For
those nonresponsive to medical therapy, portal hypertension
can be lowered by inserting a transjugular intrahepatic
portosystemic shunt [25]. However, this is limited to elective
procedures and the impact on postoperative outcome is yet
unclear [26].
During operation the sequels of anastomotic leakage can
be lowered by construction of a temporary loop ileostomy.
But the risk for complications after construction of temporary
loop ileostomy (peristomal leaking, infection, peristomal
eventration, bleeding from peristomal varices, and complica-
tions related to stoma closure) seems to be elevated in patients
with liver cirrhosis aswell [6, 27].Thus the role of a temporary
loop ileostomy in colorectal surgery in the presence of liver
cirrhosis and/or severe fibrosis remains open.
Thediagnosis of liver cirrhosis/severe fibrosis was defined
as typical nodular surface of the liver described by the
surgeon and/or histological diagnosis of liver cirrhosis/severe
fibrosis by liver biopsy. Due to possible sampling error of liver
biopsy in liver cirrhosis about one-third of the diagnoses are
missed by biopsy only [28]. The intraoperative typical nodu-
lar surface is not an unambiguous marker of liver cirrhosis as
it can be absent in about 1% of the patients with histologically
confirmed liver cirrhosis [28] and it can be present in patients
with severe fibrosis [29]. Doing both laparoscopy/laparotomy
and liver biopsy improves the diagnostic yield up to 98%
[30]. Thus, we feel that the definition of liver cirrhosis/severe
fibrosis in the present study is justified. Furthermore it fits the
real world, as during surgery surgeons sometimes have to deal
with an unexpected nodular surface of the liver. However, for
future, especially prospective studies, noninvasive methods
such as transient elastography or shear-wave elastography
potentially allow for improved risk stratification.
4.1. Limitations. Themain drawback of this study is its retro-
spective design. However, we tried to minimize a potential
bias by including all consecutive patients registered in a
prospective database who had colorectal resection with or
without anastomosis at the same institution in a predefined
period of ten years. No selection bias due to not performing
colonic or rectal anastomosis in patients with liver cirrhosis
could be detected.
Although the study has some limitations, we feel that the
results of this study are valid and that colorectal surgeons
should be aware of the higher risk of anastomotic leakage in
patients with liver cirrhosis or high-grade fibrosis.
Clearly, to confirm the results of the present study a
prospective study should be performed.
5. Conclusion
Patients with liver cirrhosis or severe fibrosis have an
increased leak rate after colonic anastomosis.
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